Please assess the completion status of the following clinical trial:

Trial Title: Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed with open angle glaucoma at the University of Pittsburgh Medical Center (UPMC) Glaucoma Clinic.~* Able to provide written informed consent to participate.~* Must be between the ages of 18 - 95.~* Patients in which further IOP lowering by SLT is necessary in the opinion of the treating physician.~Exclusion Criteria:~* Patients with eye surgery in the prior six months.~* Patients with prior or current use of topical or systemic corticosteroids or NSAIDs.~* Patients with pre-existing anterior chamber inflammation.~* Patients with known sensitivity to any of the study medications.~* Due to the age range and the disease entity, special patient populations such as children or pregnant women will not be enrolled in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).